Patterns of surveillance for late effects of BCR-ABL tyrosine kinase inhibitors in survivors of pediatric Philadelphia chromosome positive leukemias

BACKGROUND: Targeted anticancer therapies such as BCR-ABL tyrosine kinase inhibitors (TKIs) have improved outcomes for chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph + ALL). However, little is known about long-term risks of TKIs in children. Expo...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Stephanie M., Sabnis, Himalee S., Lewis, Rebecca Williamson, Effinger, Karen E., Bergsagel, John, Patterson, Briana, Mertens, Ann, Sakamoto, Kathleen M., Schapira, Lidia, Castellino, Sharon M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082962/
https://www.ncbi.nlm.nih.gov/pubmed/33926411
http://dx.doi.org/10.1186/s12885-021-08182-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082962/
https://www.ncbi.nlm.nih.gov/pubmed/33926411
http://dx.doi.org/10.1186/s12885-021-08182-z

Ejemplares similares